| 1 | Agrippal S1 (Influenza vaccination) | - | - | - | - | 1件: 46 46 |
| 2 | Belimumab plus Early Vaccination | 1件: Belimumab Belimumab | 1件: D03068
D03068
| 1件: TNFSF13B TNFSF13B 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 1件: 49 49 |
| 3 | Belimumab plus Late Vaccination | 1件: Belimumab Belimumab | 1件: D03068
D03068
| 1件: TNFSF13B TNFSF13B 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 1件: 49 49 |
| 4 | COVID-19 vaccination | - | - | - | - | 1件: 13 13 |
| 5 | Human papillomavirus vaccination (Gardasil) | 1件: Human papillomavirus type 6 L1 capsid protein antigen Human papillomavirus type 6 L1 capsid protein antigen | - | - | - | 1件: 49 49 |
| 6 | Influenza vaccination | - | - | - | - | 1件: 299 299 |
| 7 | Measles, Mumps, Rubella vaccination | - | - | - | - | 1件: 107 107 |
| 8 | Multiple (4 autologous subcutaneous T cell vaccinations with T cell lines reactive to nine myelin peptides) | - | - | - | - | 1件: 13 13 |
| 9 | Prevenar vaccination | - | - | - | - | 1件: 46 46 |
| 10 | T cell vaccination | - | - | - | - | 1件: 13 13 |
| 11 | T-Cell Vaccination | - | - | - | - | 1件: 13 13 |
| 12 | Vaccination | - | - | - | - | 1件: 49 49 |
| 13 | Vaccination against TBE | - | - | - | - | 1件: 46 46 |
| 14 | Vaccination with vaccine against hepatitis A and B | - | - | - | - | 1件: 299 299 |